Nanomedicine and Nanotoxicology: Safety Considerations in Drug Delivery

Nanomedicine has emerged as a powerful tool in drug delivery, offering unprecedented opportunities for targeted therapy and improved treatment outcomes. However, the safety considerations associated with nanomaterials and their potential toxicity cannot be overlooked. This session will focus on the intersection of nanomedicine and nanotoxicology, highlighting the importance of safety considerations in drug delivery. The session will explore the design and engineering of nanomaterials for drug delivery, including nanoparticles, nanocarriers, and nanostructured biomaterials. Discussions will delve into the physicochemical properties of nanomaterials that influence their safety profile, such as size, surface charge, and surface functionalization. Attendees will gain insights into the principles and methodologies of nanotoxicology, including in vitro and in vivo evaluation of nanomaterials for potential adverse effects. Discussions will address factors such as biocompatibility, immunogenicity, biodistribution, and long-term effects. Furthermore, the session will highlight strategies to enhance the safety of nanomedicine, including surface modification, coating strategies, and the use of biocompatible materials. Regulatory considerations and guidelines for assessing the safety of nanomedicine in preclinical and clinical settings will also be discussed. By emphasizing safety considerations in nanomedicine, this session aims to ensure the responsible development and application of nanotechnology-based drug delivery systems, minimizing potential risks and maximizing therapeutic benefits.

Overall, this session on nanomedicine and nanotoxicology will showcase the latest advancements and explore the importance of safety considerations in drug delivery. It will serve as a platform for researchers, clinicians, and industry professionals to exchange knowledge, foster collaborations, and shape the future of safe and effective nanomedicine.

    Related Conference of Nanomedicine and Nanotoxicology: Safety Considerations in Drug Delivery

    July 25-26, 2024

    34th Annual European Pharma Congress

    Frankfurt, Germany
    August 06-07, 2024

    27th World Congress on Nursing, Pharmacology and Healthcare

    Aix-en-Provence, France
    August 28-29, 2024

    4th International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    October 31-01, 2024

    37th World Congress on Pharmacology

    Amsterdam, Netherlands
    November 26-27, 2024

    3rd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2024

    3rd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 28-29, 2024

    12th International Conference on Clinical Trials

    Vancouver, Canada
    November 28-29, 2024

    39th World Congress on Pharmacology and Therapeutics

    Paris, France
    December 05-06, 2024

    17th World Drug Delivery Summit

    Dubai, UAE
    February 24-25, 2025

    2nd International Conference on Pharmacognosy

    Madrid, Spain
    March 13-14, 2025

    8th International on Pharmacy and Pharmaceutical Conference

    Prague, Czech Republic
    April 14-15, 2025

    18th European Biosimilars Congress

    Aix-en-Provence, France

    Nanomedicine and Nanotoxicology: Safety Considerations in Drug Delivery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in